Earnings Per Share of Common Stock

12 Months Ended

Dec. 31, 2020

Note 10. Earnings Per Share of Common Stock

The following table sets forth the reconciliations of the numerators and denominators for the Company’s basic and diluted earnings per share calculations for the years ended December 31, 2020, 2019, and 2018.

	Year Ended December 31,
	2020		2019			2018
Numerator:
Net income (loss) attributable to Chemours	$	219	$	(52	)	$	995
Denominator:
Weighted-average number of common shares outstanding - basic		164,681,827		164,816,839			176,968,554
Dilutive effect of the Company’s employee compensation plans (1)		1,664,702		—			5,603,467
Weighted-average number of common shares outstanding - diluted (1)		166,346,529		164,816,839			182,572,021

Basic earnings (loss) per share of common stock	$	1.33	$	(0.32	)	$	5.62
Diluted earnings (loss) per share of common stock (1)		1.32		(0.32	)		5.45

(1)

In periods where the Company incurs a net loss, the impact of potentially dilutive securities is excluded from the calculation of earnings per share as its inclusion would have an anti-dilutive effect.

The following table sets forth the average number of stock options that were anti-dilutive and, therefore, were not included in the Company’s diluted earnings per share calculations for the years ended December 31, 2020, 2019, and 2018.

	Year Ended December 31,
	2020		2019		2018
Average number of stock options		3,839,845		2,206,609		393,016